Pulmonary dysfunction 3 and 6 months following SARS-Cov2 infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033111

Enrollment

100

Registered

2023-11-30

Start date

2020-03-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary damage

Interventions

Group 1: Unselected patients. Following COVID-19 illness were followed up using questionaire and whole body phlethysmography after 3 and after 6 months. Potential functional damage at each time point

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. consent with data aquisition 2. Positive PCR test

Exclusion criteria

Exclusion criteria: Pts with COPD or lung transplant

Design outcomes

Primary

Measure	Time frame
Inclusion of at least 100 pts with a complete lung function test	—

Secondary

Measure	Time frame
Serial lung function testing 3 and 6 months following COVID infection	—

Countries

Germany

Contacts

Public ContactDamian Franzen

MVZ Franzen Institut

info@damianfranzen.de+49221-4201100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026